Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Yumanity Therapeutics CEO and leadership

Zippia score 4.3
OverviewSalaryRevenue

Reviews

Demographics

CEO & Executives

Yumanity Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Meenu Chhabra is the Yumanity Therapeutics's CEO. Yumanity Therapeutics has 23,876 employees, of which 17 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Yumanity Therapeutics executive team is 41% female and 59% male.
  • 66% of the management team is White.
  • 9% of Yumanity Therapeutics management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Yumanity Therapeutics?
Share your experience

Rate Yumanity Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Meenu Chhabra

CEO

Jeffery Kelly

Founder

Richard Morimoto

Founder

Anthony N Coles

Chairman, Executive

David A. Arkowitz

Board Member

Patricia Allen

Board Member

Richard Peters

Board Member

Ellen K. Forest

Chief Human Resources Officer

Kim Cobleigh Drapkin

Board Member

Richard A. Heyman

BOD Member

Do you work at Yumanity Therapeutics?

Does the leadership team provide a clear direction for Yumanity Therapeutics?

Yumanity Therapeutics jobs

Yumanity Therapeutics founders

Name & TitleBio
Jeffery Kelly

Founder

Richard Morimoto

Founder

Yumanity Therapeutics board members

Name & TitleBio
Anthony N Coles

Chairman, Executive

David A. Arkowitz

Board Member

Patricia Allen

Board Member

Richard Peters

Board Member

Kim Cobleigh Drapkin

Board Member

Richard A. Heyman

BOD Member

Bernard Davitian

Board Member

Cecil B. Pickett

Board Member

Franklin Berger

Board Member

Lauren Silverman

Board Member

Yumanity Therapeutics leadership demographics

Yumanity Therapeutics gender distribution in management team

  • The Yumanity Therapeutics executive team is 41% female and 59% male.
  • Yumanity Therapeutics is 36% female and 64% male company-wide.
Male
Male
59%
Company-wide: 64%
Female
Female
41%
Company-wide: 36%

Yumanity Therapeutics executives by race

Management Team:
  • The most common ethnicity among Yumanity Therapeutics executive officers is White.
  • 66% of the management team is White.
  • 13% of Yumanity Therapeutics's management is Asian.
  • 10% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 53% of employees are White.
  • 25% of employees are Asian.
  • 12% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Yumanity Therapeutics jobs nearby

Yumanity Therapeutics executives FAQs

Yumanity Therapeutics highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Yumanity Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Yumanity Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Yumanity Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Yumanity Therapeutics. The data presented on this page does not represent the view of Yumanity Therapeutics and its employees or that of Zippia.

Yumanity Therapeutics may also be known as or be related to PROTEOSTASIS THERAPEUTICS, INC., Proteostasis Therapeutics, Proteostasis Therapeutics Inc, Proteostasis Therapeutics, Inc. and Yumanity Therapeutics.